Literature DB >> 23132620

Liver resection for hepatocellular carcinoma in patients without cirrhosis.

A Thelen1, C Benckert, H-M Tautenhahn, H-M Hau, M Bartels, J Linnemann, J Bertolini, M Moche, C Wittekind, S Jonas.   

Abstract

BACKGROUND: Data on liver resection for hepatocellular carcinoma (HCC) without cirrhosis are sparse. The present study was conducted to evaluate the indications and results of liver resection for HCC with regard to safety and efficacy.
METHODS: Data for patients who had liver resection for HCC without cirrhosis between January 1996 and March 2011 were retrieved retrospectively using a prospective database containing information on all patients who underwent hepatectomy for HCC. Patient and tumour characteristics were analysed for influence on overall and disease-free survival to identify prognostic factors by univariable and multivariable analysis.
RESULTS: The 1-, 3- and 5-year overall survival rates after resection with curative intent for HCC without cirrhosis were 84, 66 and 50 per cent respectively. Disease-free survival rates were 69, 53 and 42 per cent respectively. The 90-day mortality rate was 4·5 per cent (5 of 110 patients). Surgical radicality and growth pattern of the tumour were independent prognostic factors for overall survival. Disease-free survival after resection with curative intent was independently affected by growth pattern and by the number and size of tumour nodules.
CONCLUSION: Liver resection for HCC without cirrhosis carries a low perioperative risk and excellent long-term outcome if radical resection is achieved.
Copyright © 2012 British Journal of Surgery Society Ltd. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2012        PMID: 23132620     DOI: 10.1002/bjs.8962

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

Review 1.  Assessment of the reporting of quality and outcome measures in hepatic resections: a call for 90-day reporting in all hepatectomy series.

Authors:  Michael E Egger; Joanna M Ohlendorf; Charles R Scoggins; Kelly M McMasters; Robert C G Martin
Journal:  HPB (Oxford)       Date:  2015-07-30       Impact factor: 3.647

2.  Prognostic impact of soluble intercellular adhesion molecule-1 in hepatocellular carcinoma.

Authors:  Tatsuo Shimura; Masahiko Shibata; Kenji Gonda; Yasuhide Kofunato; Teruhide Ishigame; Ryo Okada; Naoya Sato; Takashi Kimura; Akira Kenjo; Shigeru Marubashi
Journal:  Oncol Lett       Date:  2018-08-24       Impact factor: 2.967

3.  Major hepatectomy is a safe modality for the treatment of intrahepatic cholangiocarcinoma in selected patients complicated with cirrhosis.

Authors:  Hao Li; Jin-shu Wu; Xin-tian Wang; Pin Lv; Gang Liu; Bu-ning Tian; Ya-yong Li; Dao-jin Chen; Bo Jiang
Journal:  J Gastrointest Surg       Date:  2013-11-13       Impact factor: 3.452

4.  Postoperative complications affect early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yan-Ming Zhou; Xiao-Feng Zhang; Bin Li; Cheng-Jun Sui; Jia-Mei Yang
Journal:  BMC Cancer       Date:  2015-10-14       Impact factor: 4.430

5.  Radiofrequency ablation versus surgical resection for small unifocal hepatocellular carcinomas.

Authors:  J Y Lei; W T Wang; L N Yan; T F Wen; B Li
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  A nomogram predicting the recurrence of hepatocellular carcinoma in patients after laparoscopic hepatectomy.

Authors:  Yang-Xun Pan; Jian-Cong Chen; Ai-Ping Fang; Xiao-Hui Wang; Jin-Bin Chen; Jun-Cheng Wang; Wei He; Yi-Zhen Fu; Li Xu; Min-Shan Chen; Yao-Jun Zhang; Qi-Jiong Li; Zhong-Guo Zhou
Journal:  Cancer Commun (Lond)       Date:  2019-10-11

7.  TPX2 silencing exerts anti‑tumor effects on hepatocellular carcinoma by regulating the PI3K/AKT signaling pathway.

Authors:  Dan-Hong Huang; Jie Jian; Shuang Li; Yan Zhang; Li-Zhen Liu
Journal:  Int J Mol Med       Date:  2019-10-14       Impact factor: 4.101

8.  Liver resection versus transarterial chemoembolization for huge hepatocellular carcinoma: a propensity score matched analysis.

Authors:  A Bogdanovic; P Bulajic; D Masulovic; N Bidzic; M Zivanovic; D Galun
Journal:  Sci Rep       Date:  2021-02-24       Impact factor: 4.379

9.  Sec23a mediates miR-200c augmented oligometastatic to polymetastatic progression.

Authors:  Zhiwei Sun; Shixia Zhou; Junling Tang; Ting Ye; Jingyuan Li; Doudou Liu; Jian Zhou; Jianyu Wang; H Rosie Xing
Journal:  EBioMedicine       Date:  2018-10-06       Impact factor: 8.143

10.  Factors influencing early recurrence of hepatocellular carcinoma after curative resection.

Authors:  Yu Zhu; Lingling Gu; Ting Chen; Guoqun Zheng; Chao Ye; Weidong Jia
Journal:  J Int Med Res       Date:  2020-08       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.